{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:04:19Z","timestamp":1784271859256,"version":"3.55.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA233601"],"award-info":[{"award-number":["R01CA233601"]}],"id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA240941"],"award-info":[{"award-number":["CA240941"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-25-1-0309"],"award-info":[{"award-number":["HT9425-25-1-0309"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020834","name":"Miami Heart Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020834","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Leducq Network of Excellence in Cardio-Oncology"},{"name":"Royal Brompton Cardio-Oncology Centre of Excellence"},{"name":"The Big Heart Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"DOI":"10.1093\/eurheartj\/ehaf1095","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:59:16Z","timestamp":1766581156000},"page":"555-557","source":"Crossref","is-referenced-by-count":3,"title":["The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncology"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6675-4559","authenticated-orcid":false,"given":"Joerg","family":"Herrmann","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic , 200 First Street SW, Rochester, MN 55902 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiac Imaging and Cardio-Oncology Unit, La Paz University Hospital, IdiPAZ Research Institute , Paseo de la Castellana 261, Madrid 28046 ,","place":["Spain"]},{"name":"Cardiology Department, Quiron Pozuelo University Hospital , Calle Diego de Velazquez1, Pozuelo de Alarc\u00f3n 28223, Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R","family":"Lyon","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2026071702215848100_ehaf1095-B1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf315","article-title":"Immune checkpoint inhibitor-associated myocarditis: a novel risk score","author":"Power","year":"18, 2025","journal-title":"Eur Heart J"},{"key":"2026071702215848100_ehaf1095-B2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf453","article-title":"Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis","author":"Khan","year":"22, 2025","journal-title":"Eur Heart J"},{"key":"2026071702215848100_ehaf1095-B3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jaccao.2025.05.006","article-title":"Cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted therapy","volume":"7","author":"Yu","year":"2025","journal-title":"JACC CardioOncol"},{"key":"2026071702215848100_ehaf1095-B4","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1093\/eurheartj\/ehaf260","article-title":"Coronary inflammation and cardiovascular risk in breast cancer after radiotherapy","volume":"46","author":"Kotanidis","year":"2025","journal-title":"Eur Heart J"},{"key":"2026071702215848100_ehaf1095-B5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1161\/circulationaha.125.076616","article-title":"Sacubitril\/valsartan and prevention of cardiac dysfunction during adjuvant breast cancer therapy: the PRADA II randomized clinical trial","volume":"152","author":"Omland","year":"2025","journal-title":"Circulation"},{"key":"2026071702215848100_ehaf1095-B6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jaccao.2024.12.004","article-title":"SGLT2i therapy prevents anthracycline-induced cardiotoxicity in a large animal model by preserving myocardial energetics","volume":"7","author":"Medina-Hern\u00e1ndez","year":"2025","journal-title":"JACC CardioOncol"},{"key":"2026071702215848100_ehaf1095-B7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf813","article-title":"Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis","author":"Zhang","year":"3, 2025","journal-title":"Eur Heart J"},{"key":"2026071702215848100_ehaf1095-B8","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/cvr\/cvaf164","article-title":"Impaired coronary flow reserve by hyperviscosity in a mouse model of non-light chain multiple myeloma: a mechanism of coronary flow impairment at the capillary level","volume":"121","author":"Paterek","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026071702215848100_ehaf1095-B9","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1038\/s41591-025-03966-3","article-title":"Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life","volume":"31","author":"Newcomer","year":"2025","journal-title":"Nat Med"},{"key":"2026071702215848100_ehaf1095-B10","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","article-title":"Extended reduced-dose apixaban for cancer-associated venous thromboembolism","volume":"392","author":"Mah\u00e9","year":"2025","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/5\/555\/66557978\/ehaf1095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/5\/555\/66557978\/ehaf1095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:22:03Z","timestamp":1784269323000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/5\/555\/8439671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,23]]},"published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf1095","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,1]]},"published":{"date-parts":[[2026,1,23]]}}}